プロテオミックプロファイリングは,結腸直腸がんの進行の原動力としてストロマルTGF-β1/ポドプラニン軸を特定する
Silvia Di Agostino1, Davide La Padula2, Vittoria Rago3
1Department of Health Sciences, Magna Graecia University of Catanzaro, Catanzaro, 88100, Italy. sdiagostino@unicz.it.
Journal of experimental & clinical cancer research : CR
|August 22, 2025
まとめ
ポドプラニン (PDPN) は結腸直腸がん (CRC) で高濃度で,腫瘍の増殖を促進し,ストロマ細胞のサポートを強化し,潜在的な治療標的となる. 高PDPN発現は患者の生存率の低下と相関しており,予後値を示しています.
科学分野:
- 腫瘍学
- 癌 生物学
- 免疫学
背景:
- 腫瘍の微小環境 (TME) は結腸直腸がん (CRC) の発症と進行に不可欠です.
- 癌に関連した線維細胞 (CAFs) と腫瘍関連マクロファージ (TAMs) は,CRCにおける重要な調節因子であるが,その特定の役割は完全に理解されていない.
- ポドプラニン (PDPN) は,CAFで濃縮されたグリコタンパク質で,CRC TMEで高度に発現し,マクロファージの浸透とがんの進行に関連しています.
研究 の 目的:
- 結腸直腸がん (CRC) の進行におけるポドプラニン (PDPN) の役割を調査する.
- PDPNがTMEとCRC細胞の成長に影響を与えるメカニズムを解明する.
- CRCにおける潜在的な予後バイオマーカーおよび治療標的としてPDPNを評価する.
主な方法:
- CRCと隣接する正常組織のプロテオミック分析
- CRC患者コホートにおけるPDPN発現の免疫ヒスト化学と免疫光分析.
- PDPNと腫瘍細胞の成長に対するマクロファージの影響を評価するために,コカルチャーシステムを用いた機能分析.
- PDPNと患者の生存相関に関する遺伝子表現オムニバス (GEO) データの分析
主要な成果:
- PDPN発現は,CRCストロマで著しく上昇し,M2型マクロファージの浸透と再発のない生存率の低下と相関しています.
- M2型マクロファージは,ストロマ細胞のPDPNを調節し,大腸腺がん細胞の増殖を支援します.
- PDPNの減少は,TGF-β1,YAP/TAZ,RhoA/ROCK,およびECMによる腫瘍細胞増殖のストロマ細胞促進を阻害する.
結論:
- TMEは新しいPDPNに依存するメカニズムを通じてCRCの進行を容易にする.
- PDPNはCRCの潜在的な予後バイオマーカーです.
- PDPNは結腸直腸がんの有望な治療標的である.
関連する概念動画
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K


